Splenomegaly at a United States county hospital: Diagnostic evaluation of 170 patients

American Journal of the Medical Sciences

Volumn 312, Issue 4, 1996, Pages 160-165

  O'Reilly, Robert A ^a,b  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical and laboratory associations; Diagnostic groups; Hypersplenism; Massive splenomegaly; Splenomegaly

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CYTOPENIA; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HYPERSPLENISM; INFANT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; SPLENOMEGALY;

EID: 0029846153     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199610000-00003     Document Type: Article

References (17)

1. Osler W. Discussion on splenic enlargements other than leukaemic. Br Med J. 1908;2:1151-58.
2. De Cock KM, Hodgen AN, Lucas SB, Jupp RA, Slavin B, Siongok TKA, et al. Chronic splenomegaly in Nairobi, Kenya. I. Epidemiology, malarial antibody and immunoglobulin levels. Trans R Soc Trop Med Hyg. 1987;81:100-06.
3. Lipp WF, Eckstein EH, Aaron AH. Clinical significance of the palpable spleen. Gastroenterology. 1944;3:287-91.
4. Schloesser LL. Diagnostic significance of splenomegaly. Am J Med Sci. 1963;245:84-90.
5. Ebaugh FG Jr, McIntyre OR. Palpable spleens: Ten-year follow-up. Ann Intern Med. 1979;90:130-31.
6. Arkles LB, Gill GD, Molan MP. A palpable spleen is not necessarily enlarged or pathological. Med J Aust. 1986;145:15-17.
7. Dameshek W. Splenomegaly - a problem in differential diagnosis. Med Clin North Am. 1957;41:1357-67.
8. Eichner ER, Whitfield CL. Splenomegaly: An algorithmic approach to diagnosis. JAMA. 1981;246:2858-61.
9. Faller DV. Diseases of the lymph nodes and spleen. In: Wyngaarden JB, Smith LH Jr, Bennett JC; eds. Cecil: Textbook of Medicine. 19th ed. Philadelphia: WB Saunders; 1992;978-85.
10. Coetzee T. Review article: Clinical anatomy and physiology of the spleen. S Afr Med J. 1982;61:737-46.
11. Letoquart J-P, La Gamma A, Kunin N, Grosbois B, Mambrini A, Leblay R. Splenectomy for splenomegaly exceeding 1000 grams: Analysis of 47 patients. Br J Surg. 1993;80:334-35.
12. Jacobs P, Wood L, Dent DM. Splenectomy in the chronic myeloproliferative syndromes: A retrospective risk-versus-benefit analysis. S Afr Med J. 1992;81:499-503.
13. Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C. Acute transformation in nonleukemic chronic myeloproliferative disorders: Actuarial probability and main characteristics in a series of 218 patients. Acta Haematol. 1991;85: 124-27.
14. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis. 1990;12(Suppl 7):S745-S753.
15. Levin M. Acute hypersplenism and thrombocytopenia: A new presentation of disseminated mycobacterial infection in patients with acquired immunodeficiency syndrome. Acta Haematol. 1994;91:28-31.
16. Adal KA, Cockerell CJ, Petri WA Jr. Cat scratch disease, bacillary angiomatosis, and other infections due to rochalimaea. N Engl J Med. 1994;330:1509-15.
17. Firkin BG. As time goes by: Reflections on 40 years of academic medicine and biomedical research. Med J Aust. 1995;163:604-06.